Recital 23, Regulation (EU) 2024/1381

In forcesince 23 May 2024

The Commission should set deadlines for its assessment on whether the dossier submitted by the health technology developer for joint clinical assessment of the medicinal product meets the requirements laid down in Article 9(2), (3) and (4) of Regulation (EU) 2021/2282. The Commission should consult, as appropriate, the assessor and co-assessor when carrying out this assessment.